![logo](/logos/ERIS.NS.webp)
Eris Lifesciences Limited
NSE:ERIS.NS
1,448.45 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Eris Lifesciences Limited |
Symbool | ERIS.NS |
Munteenheid | INR |
Prijs | 1,448.45 |
Beurswaarde | 197,106,524,450 |
Dividendpercentage | 0% |
52-weken bereik | 792.35 - 1,522.05 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Amit Indubhushan Bakshi |
Website | https://www.eris.co.in |
An error occurred while fetching data.
Over Eris Lifesciences Limited
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)